APA

Jiang P., van der Horst C., Kimmig B., Zinsser F., Poppe B., Luetzen U., Juenemann K., Dunst J. & Siebert F. (20170726). Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome. : Brachytherapy.

Chicago

Jiang Ping, van der Horst Christof, Kimmig Bernhard, Zinsser Fabian, Poppe Bjoern, Luetzen Ulf, Juenemann Klaus-Peter, Dunst Juergen and Siebert Frank-André. 20170726. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome. : Brachytherapy.

Harvard

Jiang P., van der Horst C., Kimmig B., Zinsser F., Poppe B., Luetzen U., Juenemann K., Dunst J. and Siebert F. (20170726). Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome. : Brachytherapy.

MLA

Jiang Ping, van der Horst Christof, Kimmig Bernhard, Zinsser Fabian, Poppe Bjoern, Luetzen Ulf, Juenemann Klaus-Peter, Dunst Juergen and Siebert Frank-André. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome. : Brachytherapy. 20170726.